Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. - Wikidata - wikimedia - TriplyDB

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

http://www.wikidata.org/entity/Q44291572

about

Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response Immunoinformatics comes of age Rapid evolution of major histocompatibility complex class I genes in primates generates new disease alleles in humans via hitchhiking diversity Role of HLA Adaptation in HIV Evolution Mechanisms of HIV protein degradation into epitopes: implications for vaccine design Signature Patterns of MHC Diversity in Three Gombe Communities of Wild Chimpanzees Reflect Fitness in Reproduction and Immune Defense against SIVcpz GagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivo Evidence of Viral Adaptation to HLA Class I-Restricted Immune Pressure in Chronic Hepatitis C Virus Infection Adaptation to Human Populations Is Revealed by Within-Host Polymorphisms in HIV-1 and Hepatitis C Virus Is host-schistosome coevolution going anywhere?Molecular Basis of a Dominant T Cell Response to an HIV Reverse Transcriptase 8-mer Epitope Presented by the Protective Allele HLA-B*51:01 Terminal deoxynucleotidyl transferase establishes and broadens antiviral CD8+ T cell immunodominance hierarchies HLA class I diversity among rural rainforest inhabitants in Cameroon: identification of A*2612-B*4407 haplotype Host genetics and viral load in primary HIV-1 infection: clear evidence for gene by sex interactions Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationships A population response analysis approach to assign class II HLA-epitope restrictions KIR/HLA pleiotropism: protection against both HIV and opportunistic infections Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and Botswana Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trial The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.Host determinants of HIV-1 control in African Americans.PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.The impact of host genetic variation on infection with HIV-1.Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs.AIDS-protective HLA-B*27/B*57 and chimpanzee MHC class I molecules target analogous conserved areas of HIV-1/SIVcpz.Phylogenetic analysis consistent with a clinical history of sexual transmission of HIV-1 from a single donor reveals transmission of highly distinct variants.Defining epitope coverage requirements for T cell-based HIV vaccines: theoretical considerations and practical applications.Human immunodeficiency virus vaccine trials The HIV-1 pandemic: does the selective sweep in chimpanzees mirror humankind's future?Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection.Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection.Gorilla MHC class I gene and sequence variation in a comparative context Modelling the evolution and spread of HIV immune escape mutants CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells.Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia.

P2860

Q21131580-B2A985BA-2318-4D61-806C-A5AE3F3535E8 Q21145682-2B302987-EB0C-4647-9CCC-22BB9A326C5B Q24684291-53CCDB0C-0403-41C9-A27C-8F19F65D1ECC Q26772713-8775ED66-EFA7-44C6-80BF-B3B325E893CA Q26866505-A929FAC5-C5AC-4C50-A58B-95FBF6C2B949 Q27312114-4D62716F-2B53-47D6-9775-A43845B82684 Q27324128-9D7F8BA9-8485-4B6D-AEA2-4A1E06CFB335 Q27477614-D68B0511-A363-4AF9-86B8-084E24889660 Q27478199-514D40EA-5398-4DCC-9B15-9812861C33D8 Q27480869-6A92A405-88C4-4D59-B9BA-DE6223EE2186 Q27682033-AF88762E-4579-4C9F-A8F6-A4BC3533DD82 Q28284521-B2F4399A-0076-4DA3-A9D7-FF3B9F15B19B Q28294977-DC8407FC-C228-4763-A83C-803C3C55C216 Q28391986-D85DDED1-6999-4B52-BD94-56090E96A23E Q28394085-98E9B574-7638-4C79-A683-E2F29CCFFE13 Q28395866-C3071887-21A1-4041-8C41-1B36D0F0CB21 Q28469038-71A95107-AD75-4228-9ECC-534CEED13DAB Q28483308-20D395A2-37C3-4CC1-8F0B-54154D0F9269 Q28546809-7D4B70B7-A64B-4D15-85CA-21A6664AF262 Q28548093-938D4750-B19A-483A-8822-18685A27822A Q28607344-3219120D-E71F-4FF1-87B5-41E9DD5069C0 Q28730828-EBE1976E-F2C2-4AEA-BAD1-1848DDE05259 Q29417018-AB544DFE-739C-4157-973F-D847A3C91041 Q29417075-5260279B-C5BE-48D8-A8A7-E48B9994F08F Q29618956-21F59787-179D-44DA-8AF1-8B7BA92B1434 Q30353953-7196492D-4CC6-4B0C-B8FB-FFC96A90ECBB Q30374810-73D47DD2-48C3-4075-B594-06ABEC5E0B94 Q30386701-E59827AE-95DC-4A34-B53B-EEA15942B256 Q30392493-C4997E92-FECF-4AED-9262-869DC16AA527 Q30404569-22CBCCCC-D7E4-4B3F-B677-3E8DA8EF0563 Q30410411-ADCAC5D8-475C-44E5-B760-040D58AD07FF Q30424366-6FEA5133-358F-4E78-A48D-E0A2A6698185 Q30431054-1D9E51F0-3251-4D21-B3FD-345605141454 Q30485614-403D4043-E4CA-44A1-9587-C043CF9099BF Q30830619-4210D168-252E-4E1A-859F-505BDF082C18 Q30846768-D9871483-8DFA-48C0-9986-D0EA1580559F Q30992754-051EE29A-FD35-464C-A423-7DDE57E57EA1 Q31010282-FB2D50CE-C4DE-47F0-9B8E-0EECE60C42A1 Q31031447-56501E4D-0116-4792-BA93-181071E5A764 Q31154319-6EFA02AC-EC8F-4899-85FC-E9F9CABA3410

P2860

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

http://www.wikidata.org/entity/Q44291572

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

@en

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

@nl

type

label

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

@en

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

@nl

prefLabel

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

@en

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

@nl

P1433

Q44291572-6A1C0AC5-A2E0-4074-A052-551A1AF98CCA

P1476

Q44291572-8DFBAD03-E7E9-4136-A101-9C0B8D4ED5D8

P2093

Q44291572-20635DE9-1ADB-48A4-9869-17912C0366E0

Q44291572-23D903C6-B70B-4583-9C1F-3AB34B70A177

Q44291572-264E4277-7417-4F0A-A0AF-614BEFB7F414

Q44291572-427E564C-069C-4EC8-B626-0DE0FEC11B5F

Q44291572-55165896-C92F-4053-8009-B0A89D4FA553

Q44291572-57146DB7-7681-4610-ADA4-5BD120142212

Q44291572-5BC65B63-2BED-4FF0-8B97-D59B9436BE81

Q44291572-5EF44A4E-364E-4FD0-9966-962D04FEE4F9

Q44291572-6B962573-58D2-41F6-A878-654241B09888

Q44291572-72E6D655-E5EE-4658-8BB1-34EAAC6F1994

P2860

Q44291572-03E63617-AD9C-4007-8150-A5A2FCD38BD7

Q44291572-043007E5-D1D4-4219-BC22-ACAF3CA4EEFE

Q44291572-0DCAE8CE-F495-4A65-BEEF-C62AECAD4A5F

Q44291572-11BAD6F7-507F-49E8-88DD-94B34F7CA226

Q44291572-1551C99C-84A7-4DD1-984A-A5468C1FD49F

Q44291572-19379553-111B-4312-B221-7C215183F60A

Q44291572-3087D7B4-5398-4E60-A367-6ED810553CB0

Q44291572-30AFBCAA-7B27-4B99-A158-1859F79C5CBE

Q44291572-3F169189-BBBD-4AB3-8AAF-DE99A252A476

Q44291572-55D6949F-0180-4148-A6BB-627B8E85A012

P2888

Q44291572-7028317E-0B6E-4DD7-9F38-A4E4A159E596

P304

Q44291572-0AE02D81-2E33-4712-BFBC-53CEC3A05031

P31

Q44291572-67F8F14D-6D87-4FAF-84AB-040D2C445B9A

P356

Q44291572-83193A88-026B-4F0E-8C3C-17BB892904CC

P407

Q44291572-EE64A392-4143-43C5-B385-6B7C5E52A970

P433

Q44291572-5AA576D3-AC08-445F-AA31-39862F4313D3

P478

Q44291572-6513009E-5618-4A99-9BDA-1DBDF29F95B9

P50

Q44291572-60A65405-C1E7-4DF2-B408-1BF44B7CE1E9

Q44291572-7047A802-02CC-43BF-95F9-05DF5DF43BBF

Q44291572-72822EAF-A3B0-4F20-9269-04BE7E27D01B

Q44291572-758E6820-5C63-42F7-9041-4556FEBE4989

Q44291572-8F4F37A3-F389-4A95-8313-A7302349B38F

Q44291572-C3366A9C-06EA-4127-B2A8-71554A31AAC4

Q44291572-C3B48AA5-E30C-4B95-8715-6A9748286F50

Q44291572-C537BE7C-C6AC-44D3-85FD-63E978C2FDFB

Q44291572-CFD5FF5F-6EDD-4387-9119-43AD5A872E00

Q44291572-FD8FCF21-E3F4-496A-82D7-4D97A316E9C9

P577

Q44291572-07E396D5-EAE1-4BEE-BB28-3427271B10BD

P6179

Q44291572-3A0D5C24-6F39-4A46-BCDB-2635C602E3A8

P698

Q44291572-240B27CB-71AA-4259-9BD3-7215AAB12AE2

P356

P1433

P1476

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

@en

P2093

Cheryl Day

http://www.w3.org/2001/XMLSchema#string

Christina Thobakgale

http://www.w3.org/2001/XMLSchema#string

Corey Moore

http://www.w3.org/2001/XMLSchema#string

Danni Ramduth

http://www.w3.org/2001/XMLSchema#string

Ian James

http://www.w3.org/2001/XMLSchema#string

Isobella Honeyborne

http://www.w3.org/2001/XMLSchema#string

James Mullins

http://www.w3.org/2001/XMLSchema#string

James Szinger

http://www.w3.org/2001/XMLSchema#string

Katja J Pfafferott

http://www.w3.org/2001/XMLSchema#string

Linda D Barber

http://www.w3.org/2001/XMLSchema#string

P2860

HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS

Genetics of susceptibility to human infectious disease

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Do infectious diseases drive MHC diversity?

Advantage of rare HLA supertype in HIV disease progression.

Cellular immune responses to HIV.

P2888

P304

769-775

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE03113

http://www.w3.org/2001/XMLSchema#string

P407

P433

7018

http://www.w3.org/2001/XMLSchema#string

P478

432

http://www.w3.org/2001/XMLSchema#string

P50

Hoosen Coovadia

Bruce D. Walker

Christian Brander

Alasdair Leslie

Philip J. R. Goulder

Photini Kiepiela

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1037227812

http://www.w3.org/2001/XMLSchema#string

P698

15592417

http://www.w3.org/2001/XMLSchema#string